162 related articles for article (PubMed ID: 8103618)
1. [Movement disorders induced by neuroleptic therapy].
Almeida R; Santos MV
Acta Med Port; 1993 Jun; 6(6):239-44. PubMed ID: 8103618
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of antipsychotic drug-induced movement disorders.
Casey DE
J Clin Psychiatry; 2004; 65 Suppl 9():25-8. PubMed ID: 15189109
[TBL] [Abstract][Full Text] [Related]
3. Movement disorders with neuroleptic drug treatment.
Tarsy D
Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
[TBL] [Abstract][Full Text] [Related]
4. [Drug induced movement disorders: role of antipsychotic drugs].
Damásio J; Carvalho S
Acta Med Port; 2011 Dec; 24 Suppl 4():915-22. PubMed ID: 22863500
[TBL] [Abstract][Full Text] [Related]
5. Neurologic complications of drugs. Tardive dyskinesias, neuroleptic malignant syndrome, and cocaine-related syndromes.
Rodnitzky RL; Keyser DL
Psychiatr Clin North Am; 1992 Jun; 15(2):491-510. PubMed ID: 1351285
[TBL] [Abstract][Full Text] [Related]
6. The possible role of dopamine autoreceptors in neuroleptic atypicality.
Javitt DC; Weinstein SL; Opler LA
Psychiatr Dev; 1988; 6(1):57-71. PubMed ID: 2902622
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced movement disorders.
Gershanik OS
Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):369-76. PubMed ID: 8099509
[TBL] [Abstract][Full Text] [Related]
8. Neuroleptic-induced movement disorders: deconstructing extrapyramidal symptoms.
Trosch RM
J Am Geriatr Soc; 2004 Dec; 52(12 Suppl):S266-71. PubMed ID: 15541167
[No Abstract] [Full Text] [Related]
9. Movement disorders associated with neuroleptic treatment.
Wirshing WC
J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
[TBL] [Abstract][Full Text] [Related]
10. Algorithms for neuroleptic-associated tardive movement disorders.
Akiyama K
Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S23-9. PubMed ID: 10560894
[TBL] [Abstract][Full Text] [Related]
11. [Current status of our knowledge of the neurotropic side effects of neuroleptic drugs].
Sabbatini F; Pinessi L; Gentile S; De Mattei M; Portaleone P
Minerva Psichiatr; 1983; 24(4):145-53. PubMed ID: 6145083
[No Abstract] [Full Text] [Related]
12. Neuronal basis of neuroleptic-induced extrapyramidal side effects.
Ossowska K
Pol J Pharmacol; 2002; 54(4):299-312. PubMed ID: 12523484
[TBL] [Abstract][Full Text] [Related]
13. [Are the antipsychotic and side-effects of neuroleptics imperfectly known?].
Schulz P
Biomed Pharmacother; 1987; 41(1):31-3. PubMed ID: 2886159
[TBL] [Abstract][Full Text] [Related]
14. Neuroleptic drugs and tardive dyskinesia.
Bittker TE
Ariz Med; 1981 Sep; 38(9):708-9. PubMed ID: 6117266
[No Abstract] [Full Text] [Related]
15. [Late extrapyramidal hyperkinesis and neuroleptic withdrawal dyskinesia. Practical problems].
Hoffmann C; Faust V
Fortschr Med; 1983 Mar; 101(11):470-6. PubMed ID: 6133824
[TBL] [Abstract][Full Text] [Related]
16. [Neuroleptic-induced movement disorders: historical perspectives].
Wolf MA; Yassa R; Llorca PM
Encephale; 1993; 19(6):657-61. PubMed ID: 12404786
[TBL] [Abstract][Full Text] [Related]
17. Tardive dyskinesia: pathophysiology and animal models.
Casey DE
J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
[TBL] [Abstract][Full Text] [Related]
18. Are movement disorders the most serious side effects of maintenance therapy with antipsychotic drugs?
Lidsky TI; Labuszewski T; Levine FM
Biol Psychiatry; 1981 Dec; 16(12):1189-94. PubMed ID: 6130799
[TBL] [Abstract][Full Text] [Related]
19. [Tardive dyskinesia].
Kato M; Watanabe K
Ryoikibetsu Shokogun Shirizu; 2003; (38):183-7. PubMed ID: 12876961
[No Abstract] [Full Text] [Related]
20. Antipsychotic agents: a review.
Dilsaver SC
Am Fam Physician; 1993 Jan; 47(1):199-204. PubMed ID: 8418582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
